The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease -: A prospective study

被引:89
|
作者
Haider, AW
Wilson, PWF
Larson, MG
Evans, JC
Michelson, EL
Wolf, PA
O'Donnell, CJ
Levy, D
机构
[1] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA
[2] NHLBI, Bethesda, MD 20892 USA
[3] Boston Univ, Sch Med, Prevent Med & Epidemiol Sect, Boston, MA 02215 USA
[4] MCP Hahnemann Univ Hosp, Div Cardiol, Philadelphia, PA USA
[5] AstraZeneca, Wayne, PA USA
[6] Beth Israel Hosp, Div Cardiol & Clin Epidemiol, Boston, MA USA
关键词
D O I
10.1016/S0735-1097(02)02272-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES We sought to determine whether seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus (CMV) is an independent predictor of incident cardiovascular disease. BACKGROUND Recent reports have suggested that infections may contribute to risk of cardiovascular disease. However, prospective studies of these associations in a free-living population are lacking. METHODS We measured serum H. pylori IgG, C pneumoniae IgG and IgA, and CMV IgG levels in Framingham Heart Study cohort participants. Blood samples were drawn during the 16th biennial examination cycle (1979 to 1982) from 1,187 participants free of cardiovascular disease (mean age 69 years) and stored at -20degreesC. A pooled primary end point of myocardial infarction, atherothrombotic stroke, and coronary heart disease deaths was studied in relation to serology. Using a Cox model, hazard ratios (HR) and 95% confidence intervals (CI) were calculated, adjusting for age, gender, and established risk factors. RESULTS Seropositivity to H. pylori IgG, C pneumoniae IgG, C pneumoniae IgA, and CMV IgG was 60%, 45%, 11%, and 69%, respectively. During 10 years of follow-up, incident cardiovascular disease occurred in 199 participants (16.8%). In age- and gender-adjusted models, H. pylori IgG (HR 1.09, 95% CI 0.81 to 1.46), C. pneumoniae IgG (HR 0.91, 95% CI 0.68 to 1.20), C pneumoniae IgA (HR 0.65, 95% CI 0.39 to 1.07), and CMV IgG (HR 0.84, 95% CI 0.62 to 1.12) were not associated with incident cardiovascular disease. These associations were further attenuated after adjustment for risk factors including body mass index, total and high-density lipoprotein cholesterol, diabetes mellitus, smoking, and hypertension. These estimates did not change for the individual components of cardiovascular disease, and seropositivity to more than one organism did not alter these risk estimates substantially. CONCLUSIONS In this elderly cohort, chronic H. pylori, C pneumoniae, and CMV infections, as evidenced by seropositivity, were not associated with increased risk for cardiovascular disease. Additional studies are needed to determine the relations of chronic infections to cardiovascular disease risk in younger persons. (J Am Coll Cardiol 2002;40:1408-13). (C) 2002 by the American College of Cardiology Foundation.
引用
收藏
页码:1408 / 1413
页数:6
相关论文
共 50 条
  • [1] Seropositivity to Chlamydia pneumoniae or Helicobacter pylori and coronary artery disease
    Sotiropouios, Alexios
    Gikas, Aristofanis
    Skourtis, Sotirlos
    Merkouris, Panagiotis
    Pentzeridis, Panagiotis
    Polydorou, Antonios
    Pappas, Stavros
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 109 (03) : 420 - 421
  • [2] Association of H pylori, C pneumoniae and Cytomegalovirus seropositivity with cardiovascular disease in the Framingham Heart Study
    Haider, AW
    Wilson, PWF
    Larson, MG
    O'Donnell, CJ
    Wolf, PA
    D'Agostino, RB
    Michelson, EL
    Levy, D
    [J]. CIRCULATION, 1999, 100 (18) : 232 - 232
  • [3] Is seropositivity enough to show the association between coronary artery disease and Chlamydia pneumoniae and Helicobacter pylori infection?
    Yetkin, Gulay
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 113 (03) : 432 - 434
  • [4] Association between angiographic evidence of coronary artery disease and seropositivity for Helicobacter pylori and Chlamydia pneumoniae infection
    Sharifkazemi, MB
    Marvasti, VE
    Hoseini, E
    Mohammadian, R
    Roshanzamir, S
    Ekramzadeh, S
    Rezayee, V
    Samim, MM
    [J]. SAUDI MEDICAL JOURNAL, 2005, 26 (04) : 684 - 685
  • [5] ROLE OF CHLAMYDIA PNEUMONIAE, HELICOBACTER PYLORI AND CYTOMEGALOVIRUS IN CORONARY ARTERY DISEASE
    Al-Ghamdi, Abdullah
    Jiman-Fatani, Asif Ahmed
    El-Banna, Hassan
    [J]. PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 24 (02) : 95 - 101
  • [6] Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women
    Bloemenkamp, DGM
    Mali, WPTM
    Tanis, BC
    Rosendaal, FR
    van den Bosch, MAAJ
    Kemmeren, JM
    Algra, A
    Ossewaarde, JM
    Visseren, FLJ
    van Loon, AM
    van der Graaf, Y
    [J]. ATHEROSCLEROSIS, 2002, 163 (01) : 149 - 156
  • [7] No association of Helicobacter pylori seropositivity with coronary heart disease in a prospective study.
    Folsom, AR
    Nieto, FJ
    Sorlie, P
    Chambless, LE
    Graham, DY
    [J]. CIRCULATION, 1997, 96 (08) : 545 - 545
  • [8] Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile
    Hoffmeister, A
    Rothenbacher, D
    Bode, G
    Persson, K
    März, W
    Nauck, MA
    Brenner, H
    Hombach, V
    Koenig, W
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (03) : 427 - 432
  • [9] Chlamydia pneumoniae seropositivity and cardiovascular risk factors:: The InCHIANTI study
    Blanc, P
    Corsi, AM
    Gabbuti, A
    Peduzzi, C
    Meacci, F
    Olivieri, F
    Lauretani, F
    Francesco, M
    Ferrucci, L
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (10) : 1626 - 1631
  • [10] Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women
    Ridker, PM
    Hennekens, CH
    Buring, JE
    Kundsin, R
    Shih, J
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 131 (08) : 573 - +